| Literature DB >> 27628946 |
Benjamin F Rahemtulla1, Hugh F Clark2, Martin D Smith3.
Abstract
A catalytic enantioselective route to C1 - and C2 -symmetric 2,2'-spirobiindanones has been realized through an intramolecular enolate C-acylation. This reaction employs a chiral ammonium counterion to direct the acylation of an in situ generated ketone enolate with a pentafluorophenyl ester. This reaction constitutes the first example of a direct catalytic enantioselective C-acylation of a ketone and provides an efficient and highly enantioselective route to axially chiral spirobiindanediones. These products can be diastereoselectively derivatized, offering access to a range of functionalized spirocyclic architectures.Entities:
Keywords: C-acylation; axial chirality; counterion; enantioselective synthesis; organocatalysis; phase-transfer
Year: 2016 PMID: 27628946 PMCID: PMC5113699 DOI: 10.1002/anie.201607731
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336
Scheme 1Previous work and strategy for enantioselective C‐acylation.
Optimization: cation‐directed enantioselective C‐acylation.[a]
| Entry | R1 | Catalyst | Base | e.r.[b] |
|---|---|---|---|---|
| 1 | Ph | Bu4NBr | K2CO3 (aq.)[c] | 50:50 |
| 2 | Ph |
| K2CO3 (aq.)[c] | 56:44 |
| 3 | Ph |
| KOH (aq.)[c] | – |
| 4 | Ph |
| KOH (s) | 59:41 |
| 5 | Ph |
| KOH (s) | 69:31 |
| 6 | Ph |
| NaOPh (s) | 51:49 |
| 7 | C6F5 |
| KOH (s) | 42:58 |
| 8 | C6F5 |
| KOH (s) | 79:21 |
| 9 | C6F5 |
| KOH (s) | 25:75 |
| 10 | C6F5 |
| KOH (s) | 36:64 |
| 11 | C6F5 |
| KOH (s) | 29:71 |
| 12 | C6F5 |
| KOH (s) | 17:83 |
| 13 | C6F5 |
| KOH (s) | 88:12 |
| 14 | C6F5 |
| K3PO4 (s) | 89:11 |
| 15 | C6F5 |
| K3PO4 (aq.)[c] | 97:3 |
|
| ||||
[a] Conditions: substrate 7 or 8 (0.02 mmol), catalyst (10 mol %), solid base (1.0 equiv.), PhMe ([substrate]=0.1 mol dm−3), RT, 48 h. [b] e.r. determined by chiral stationary phase HPLC. [c] base: 50 % aq., w/w, 10.0 equiv.
Scope of cation‐directed enantioselective direct C‐acylation.
|
|
Conditions: substrate (0.10 mmol), catalyst (10 mol %), K3PO4 (50 % aq., w/w, 10.0 equiv.), PhMe ([substrate]=0.1 mol dm−3), RT, 48 h. e.r. determined by chiral stationary phase HPLC; yields refer to isolated materials.
Scheme 2Chemoselective derivatizations of the spirobindanone core. Conditions: a) N‐Bromosuccinimide (1.0 equiv.), AIBN (0.02 equiv.), CCl4, 80 °C. b) DIBALH (1.0 m in THF, 3.0 equiv.), t‐BuLi (1.7 m in pentane, 3.0 equiv.), THF, −78 °C. c) DIBALH (1.0 m in hexanes, 3.3 equiv.), t‐BuLi (1.7 m in pentane, 3 equiv.), THF, −78 °C. d) 4‐F(C6H4)B(OH)2 (1.5 equiv.), Pd(PPh3)4 (2 mol %), Na2CO3, Toluene/H2O (2.3:1, v/v), reflux. e) B2Pin2 (1.2 equiv.), Pd(dppf)Cl2 (5 mol %), KOAc (3.0 equiv.), 1,4‐dioxane, reflux. e.r. determined by chiral stationary phase HPLC; d.r. determined by examination of the crude 1H NMR spectra. Yields refer to isolated materials.